In vitro scientist or senior scientist for Minerva Imaging
Denne stilling er desværre ikke længere ledig.
Se alle ledige stillinger
Ølstykke
We are looking for an experienced scientist or senior scientist with a strong background in cellular and biochemical assays. The ideal candidate takes ownership of projects, is proactive, and sets high quality standards for both study conduction and data deliveries. It is essential that you have a positive attitude and enjoy working with changing priorities and deadlines.
About us
Minerva Imaging’s vision is to become the leading contract research and contract development organization for targeted radionuclide therapy and imaging, enabling improved treatment regimens for cancer patients. Our focus is on in vitro assays and the use of advanced animal models for in vivo and ex vivo molecular imaging for translational research and drug development.
We aim to excel in delivering customized cancer radiopharmaceutical research and serve as an extended research team to our collaborators. We have built a global leading R&D platform for targeted radionuclide therapy and Contract Development and Manufacturing (CDMO) to enable integrated planning and faster execution of promising new radionuclide theragnostic projects in close collaboration with leading researchers, biotech, and pharmaceutical companies.
Minerva is at the forefront of R&D in the theragnostic area. We are in a very fast-paced environment, where our scientists directly impact the advancement of new improved, and lifesaving drugs for seriously ill cancer patients. We have the ambition to make a difference for our clients, collaborating on advancing new treatment modalities for patients.
What are we looking for?
Minerva Imaging is offering a wide range of services, and we are now looking for a candidate to expand our in vitro assays and modelsteam. The ideal candidate has a great scientific understanding, preferably within the oncology space combined with cellular and biochemical assay development skills and interest.
Your tasks:
Required qualifications:
As a person you:
Please submit your application no later than December 22, 2023. The application must include a motivated cover letter and a CV addressing the listed qualifications. Applications will be evaluated continuously.
If you have questions regarding the position, please contact Senior Scientist and Team leader Sebastian Gnosa at [email protected]
About Minerva Imaging
Minerva Imaging is a scientifically driven CRO/CDMO founded in 2011 counting 130 employees. Our focus is on the use of advanced animal models within oncology and cardiovascular diseases and in vivo molecular imaging for translational research and drug development.
We engage with our collaborators to understand their scientific questions and discuss how our methods and capabilities can provide answers. We are rapidly growing, and the right candidate will be a key contributor to maintaining the scientific foundation and our approach to research while expanding our business. You will join a highly specialized CRO/CDMO, with ambitions of taking disease treatment to the next generation of personalized medicines.
We are an informal organization with a strong focus on open and honest communication. We value humor and a natural care for one another, meaning stepping up and lending a helping hand to a colleague when needed.
We offer a combined compensation package which includes a base salary, pension and an attractive bonus program. We believe in creating an agile working environment, so we have flexible working options including the possibility of partly working from home. We care about our employees’ well-being and offer health insurance and a quality conscious lunch scheme and arrange monthly social activities. Minerva Imaging is an equal opportunity employer and encourage candidates of all backgrounds and experiences to apply.
Follow Minerva Imaging on LinkedIn for the latest news.
Kilde: Jobnet.dk
About us
Minerva Imaging’s vision is to become the leading contract research and contract development organization for targeted radionuclide therapy and imaging, enabling improved treatment regimens for cancer patients. Our focus is on in vitro assays and the use of advanced animal models for in vivo and ex vivo molecular imaging for translational research and drug development.
We aim to excel in delivering customized cancer radiopharmaceutical research and serve as an extended research team to our collaborators. We have built a global leading R&D platform for targeted radionuclide therapy and Contract Development and Manufacturing (CDMO) to enable integrated planning and faster execution of promising new radionuclide theragnostic projects in close collaboration with leading researchers, biotech, and pharmaceutical companies.
Minerva is at the forefront of R&D in the theragnostic area. We are in a very fast-paced environment, where our scientists directly impact the advancement of new improved, and lifesaving drugs for seriously ill cancer patients. We have the ambition to make a difference for our clients, collaborating on advancing new treatment modalities for patients.
What are we looking for?
Minerva Imaging is offering a wide range of services, and we are now looking for a candidate to expand our in vitro assays and modelsteam. The ideal candidate has a great scientific understanding, preferably within the oncology space combined with cellular and biochemical assay development skills and interest.
Your tasks:
- Plan and execute external and internal research activities within oncology and cardiovascular diseases
- Plan and conduct cellular and biochemical assays to characterize and provide mechanism-of-action data for drug candidates primarily within targeted radionuclide therapy, including handling of radioactive materials
- Write study protocols, analyze data, and report study results
- Participate in the development and setup of new in vitro assays in collaboration with senior scientists
- Communicate with all stakeholders both internal and external, from technicians to sponsor representatives
- Supervise younger scientists and technicians.
- Be an active member in our in vitro assays and models team
Required qualifications:
- PhD degree within natural or life sciences
- Broad knowledge in oncology, biochemistry and drug development
- Scientific knowledge and hands on technical expertise in development of biochemical- and cell-based-assays such as, binding-, cytotoxicity- and proliferation-assays
- Strong analytical mindset combined with a make it work attitude
- Willingness to work with radioactive materials
- Ability to plan, execute and report internal and external projects in collaboration with senior scientist
- Excellent communication skills in English, both written and oral
- Previous work experience within targeted radionuclide therapy is considered as an advantage but is not a must
As a person you:
- Thrive in a fast paced, dynamic, service organization where our collaborators rely on our ability to run the extra mile
- Think independently and act as a responsible colleague who is comfortable speaking your mind
- Have a strong interest in working hands-on with molecular and cell-based assays
- Take responsibility for driving key project activities to completion
- Are social, positive and bring a lot of drive
- Can work independently but also as a team player in an international environment.
Please submit your application no later than December 22, 2023. The application must include a motivated cover letter and a CV addressing the listed qualifications. Applications will be evaluated continuously.
If you have questions regarding the position, please contact Senior Scientist and Team leader Sebastian Gnosa at [email protected]
About Minerva Imaging
Minerva Imaging is a scientifically driven CRO/CDMO founded in 2011 counting 130 employees. Our focus is on the use of advanced animal models within oncology and cardiovascular diseases and in vivo molecular imaging for translational research and drug development.
We engage with our collaborators to understand their scientific questions and discuss how our methods and capabilities can provide answers. We are rapidly growing, and the right candidate will be a key contributor to maintaining the scientific foundation and our approach to research while expanding our business. You will join a highly specialized CRO/CDMO, with ambitions of taking disease treatment to the next generation of personalized medicines.
We are an informal organization with a strong focus on open and honest communication. We value humor and a natural care for one another, meaning stepping up and lending a helping hand to a colleague when needed.
We offer a combined compensation package which includes a base salary, pension and an attractive bonus program. We believe in creating an agile working environment, so we have flexible working options including the possibility of partly working from home. We care about our employees’ well-being and offer health insurance and a quality conscious lunch scheme and arrange monthly social activities. Minerva Imaging is an equal opportunity employer and encourage candidates of all backgrounds and experiences to apply.
Follow Minerva Imaging on LinkedIn for the latest news.
Kilde: Jobnet.dk
Information og data
Denne ledige stilling har jobtypen "Kemiker", og befinder sig i kategorien "Sundhed og forskning".
Arbejdsstedet er beliggende i Ølstykke.
Jobbet er oprettet på vores service den 22.11.2023, men kan have været deaktiveret og genaktiveret igen.
Dagligt opdateret: Dette job opdateres dagligt ud fra jobudbyderens hjemmeside via vores søgemaskineteknologi og er aktivt lige nu.
- Kemiker
- Ølstykke
- Fredag den 22. december 2023
Statistik over udbudte jobs som kemikere i Ølstykke
Herunder ser du udviklingen i udbudte kemiker i Ølstykke over tid. Bemærk at jobs der ikke har en bestemt geografi ikke er medtaget i tabellen. I den første kolonne ser du datoen. I den næste kolonne ser du det samlede antal kemikere.
Se flere statistikker her:
Statistik over udbudte kemikere i Ølstykke over tid
Dato | Alle jobs som kemikere |
---|---|
23. december 2024 | 0 |
22. december 2024 | 0 |
21. december 2024 | 0 |
20. december 2024 | 0 |
19. december 2024 | 0 |
18. december 2024 | 0 |
17. december 2024 | 0 |
16. december 2024 | 0 |
15. december 2024 | 0 |
14. december 2024 | 0 |
13. december 2024 | 0 |
12. december 2024 | 0 |
11. december 2024 | 0 |
10. december 2024 | 0 |
9. december 2024 | 0 |
8. december 2024 | 0 |
7. december 2024 | 0 |
6. december 2024 | 0 |
5. december 2024 | 0 |
4. december 2024 | 0 |
3. december 2024 | 0 |
2. december 2024 | 0 |
1. december 2024 | 0 |
30. november 2024 | 0 |
29. november 2024 | 0 |
28. november 2024 | 0 |
27. november 2024 | 0 |
26. november 2024 | 0 |
25. november 2024 | 0 |
24. november 2024 | 0 |
23. november 2024 | 0 |